甲基普雷迪尼索隆对降低高风险患者严重COVID-19和死亡率的影响:一项回顾性研究
Yan Xiao1, Jinwei Wang1, Kai Yang1
1Respiratory Infection and Critical Disease Diagnosis and Treatment, Beijing Gobroad Boren Hospital, Beijing, China.
SAGE open medicine
|September 11, 2024
概括
低剂量甲基普雷迪尼索隆有效治疗高风险的COVID-19患者. 在CT扫描上及时使用地面玻璃不透明度减少严重疾病和死亡率,促进炎症缓解.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
背景情况:
- 葡萄糖皮质类药物对严重的COVID-19有效,但指南缺乏对高风险患者的全面指示.
- 高风险COVID-19患者的有效治疗策略仍然是一个重大的临床挑战.
研究的目的:
- 为高风险的COVID-19患者确定最佳治疗方法.
- 分析甲基普雷迪尼索隆对高风险队列中严重的COVID-19结果的影响.
主要方法:
- 对33名高风险COVID-19患者的流行病学,临床和实验室数据的回顾性分析.
- 分类为轻度至中度 (n=26) 和严重 (n=7) 的COVID-19组.
- 胸部CT成像指导了甲基普雷迪尼索隆的使用,结果包括机械通风持续时间,ICU停留时间和28天死亡率.
主要成果:
- 12.1%的患者需要机械通风,平均PaO2/FiO2比率为279.
- 没有检测到共感染.
- 机械通风持续时间平均为16天,ICU停留时间为11天,28天死亡率为3.0%.
结论:
- 低剂量及时服用甲基普雷迪尼索隆与高风险个体的严重COVID-19发病率和死亡率的降低有关.
- 对于在CT扫描上出现地面玻璃不透明的患者,连续低剂量甲基普雷迪尼索隆有助于炎症缓解,并防止严重的疾病进展或死亡.
更多相关视频
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
228
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
228
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188
Antiasthma Drugs: Methylxanthines
209
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
209
Acute Respiratory Failure-V
124
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124
Pulmonary Tuberculosis I
225
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
225


